Protein Ingestion and Skeletal Muscle Atrophy
Primary Purpose
Muscle Atrophy
Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Lower limb immobilisation (leg brace) with varying levels of protein intake
Sponsored by
About this trial
This is an interventional basic science trial for Muscle Atrophy
Eligibility Criteria
Inclusion Criteria:
- BMI >18 and <28 no prescription medications or current illness.
Exclusion Criteria:
- BMI <18 and >28 current prescription medication no history of leg injury.
- Smoker
- Medical conditions including (cardiovascular disease ((e.g. hypertension)), metabolic disease ((e.g. type 2 diabetes)), any personal or family history of deep vein thrombosis.
Sites / Locations
- Sport and Health Science
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Experimental
Arm Label
High protein
Low protein
Minimum protein
Arm Description
Outcomes
Primary Outcome Measures
Muscle size
Secondary Outcome Measures
Muscle strength
Full Information
NCT ID
NCT03797781
First Posted
January 7, 2019
Last Updated
September 25, 2020
Sponsor
University of Exeter
1. Study Identification
Unique Protocol Identification Number
NCT03797781
Brief Title
Protein Ingestion and Skeletal Muscle Atrophy
Official Title
Understanding the Role of Protein Ingestion on Skeletal Muscle Atrophy During an Acute Period of Disuse
Study Type
Interventional
2. Study Status
Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
October 31, 2017 (Actual)
Primary Completion Date
December 31, 2019 (Actual)
Study Completion Date
December 31, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Exeter
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The effect of different protein intakes on skeletal muscle atrophy during short term unilateral leg immobilisation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Muscle Atrophy
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
33 (Actual)
8. Arms, Groups, and Interventions
Arm Title
High protein
Arm Type
Experimental
Arm Title
Low protein
Arm Type
Experimental
Arm Title
Minimum protein
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Lower limb immobilisation (leg brace) with varying levels of protein intake
Intervention Description
Single leg immobilisation via leg brace and crutches, the groups have different amounts of protein intake
Primary Outcome Measure Information:
Title
Muscle size
Time Frame
3 days
Secondary Outcome Measure Information:
Title
Muscle strength
Time Frame
3 days
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
BMI >18 and <28 no prescription medications or current illness.
Exclusion Criteria:
BMI <18 and >28 current prescription medication no history of leg injury.
Smoker
Medical conditions including (cardiovascular disease ((e.g. hypertension)), metabolic disease ((e.g. type 2 diabetes)), any personal or family history of deep vein thrombosis.
Facility Information:
Facility Name
Sport and Health Science
City
Exeter
State/Province
Devon
ZIP/Postal Code
EX1 2LU
Country
United Kingdom
12. IPD Sharing Statement
Citations:
PubMed Identifier
32469388
Citation
Kilroe SP, Fulford J, Jackman S, Holwerda A, Gijsen A, van Loon L, Wall BT. Dietary protein intake does not modulate daily myofibrillar protein synthesis rates or loss of muscle mass and function during short-term immobilization in young men: a randomized controlled trial. Am J Clin Nutr. 2021 Mar 11;113(3):548-561. doi: 10.1093/ajcn/nqaa136.
Results Reference
derived
Learn more about this trial
Protein Ingestion and Skeletal Muscle Atrophy
We'll reach out to this number within 24 hrs